Search Results
Beat AML: promising results with enasidenib for AML in the frontline
Personalized AML therapy with John Byrd: the beat AML trial and more
Ivosidenib or enasidenib with chemotherapy for AML produces deep remissions
Phase I Results for Enasidenib in AML
Enasidenib in mIDH relapsed and refractory AML
Early Results from the Beat AML Master Trial
Rationale for Enasidenib in AML
Beat AML Trial: Rapid Genetic Screening in Acute Myeloid Leukemia
IDH Inhibitors for AML
Phase II trial of enasidenib in IDH2-mutant MDS
Enasidenib in Relapsed/Refractory Mutant IDH2 AML
Encouraging patients to participate in AML trials
